FABP4 plasma levels are increased in familial combined hyperlipidemia

FABP4 plasma levels are increased in familial combined hyperlipidemia

The lipid profile of familial combined hyperlipidemia (FCHL) shares some characteristics with atherogenic dyslipidemia seen in diabetes, metabolic syndrome, and obesity. Adipocyte fatty acid-binding protein 4 (FABP4) appears to be a determinant of atherogenic dyslipidemia. We examined relationships...

Full description

Bibliographic Details
Main Authors: Anna Cabré, Iolanda Lázaro, Montserrat Cofán, Estibaliz Jarauta, Núria Plana, Angel L. Garcia-Otín, Juan F. Ascaso, Raimón Ferré, Fernando Civeira, Emilio Ros, Lluís Masana
Format: Article
Language:English
Published: Elsevier 2010-05-01
Series:Journal of Lipid Research
Subjects:
dyslipidemia
FCHL
insulin resistance
obesity
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520410727

Similar Items

Similar Items